VTGNNasdaqPharmaceutical PreparationsFiscal year ends March 31
Vistagen Therapeutics, Inc.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.20+0.00 (+1.55%)
Close on Oct 19, 2026
- Market cap
- $8.73M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Jun 7, 2023 | 1-for-30 reverse | Earlier per-share figures multiplied by 30 |
| Jun 6, 2023 | 1-for-30 reverse | Earlier per-share figures multiplied by 30 |
| Nov 19, 2014(first seen in filings) | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Aug 14, 2014 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |